Precocious puberty

Paediatrics and Child Health

Volumn 17, Issue 9, 2007, Pages 343-348

  Dixon, J R ^a   Ahmed, S F ^a  

^a ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

Author keywords

follicle stimulating hormone; luteinizing hormone; management; puberty; sex steroid

Indexed keywords

ANASTROZOLE; ANDROGEN; BUSERELIN; CYPROTERONE ACETATE; FLUDROCORTISONE; GONADORELIN; GONADORELIN AGONIST; GONADORELIN DERIVATIVE; GONADOTROPIN; GOSERELIN; GROWTH HORMONE; HYDROCORTISONE; LETROZOLE; LEUPRORELIN; OXANDROLONE; SEX HORMONE; THYROXINE; TRIPTORELIN;

ADRENAL SUPPRESSION; ADRENAL TUMOR; ALBRIGHT SYNDROME; ANAMNESIS; ARTICLE; AUTOSOMAL DOMINANT DISORDER; BODY HEIGHT; BONE DENSITY; BONE RADIOGRAPHY; BREAST DEVELOPMENT; CLINICAL ASSESSMENT; COMPUTER ASSISTED TOMOGRAPHY; CONGENITAL ADRENAL HYPERPLASIA; DEPRESSION; DIAGNOSTIC IMAGING; ECHOGRAPHY; GONADOTROPIN RELEASE; GROWTH RATE; GROWTH RETARDATION; HUMAN; HYPOTHYROIDISM; LETHARGY; NIGHTMARE; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PRECOCIOUS PUBERTY; PUBERTY; SEXUAL MATURATION; SIDE EFFECT; SINGLE DRUG DOSE; SOCIAL PSYCHOLOGY; TESTOTOXICOSIS; WITHDRAWAL BLEEDING;

EID: 34548400842     PISSN: 17517222     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.paed.2007.06.009     Document Type: Article

References (38)

1. Fernandez-Fernandez R., Martini A.C., Navarro V.M., et al. Novel signals for the integration of energy balance and reproduction. Mol Cell Endocrinol (2006) 254-255, 127-132
2. Ibanez L., Jimenez R., and de Zegher F. Early puberty-menarche after precocious pubarche: relation to prenatal growth. Pediatrics 117 (2006) 117-121
3. Ojeda S.R., Lomniczi A., Mastronardi C., et al. Minireview: the neuroendocrine regulation of puberty: is the time ripe for a systems biology approach?. Endocrinology 147 (2006) 1166-1174
4. Ahmed S.F. Gonadal disorders. In: Kelnar C., Savage M., Saenger P., and Cowell C. (Eds). Growth disorders. 2nd edn. (2007), Hodder Arnold, London
5. Marshall W.A., and Tanner J.M. Variations in pattern of pubertal changes in girls. Arch Dis Child 44 (1969) 291-303
6. Marshall W.A., and Tanner J.M. Variations in the pattern of pubertal changes in boys. Arch Dis Child 45 (1970) 13-23
7. Parent A.S., Teilmann G., Juul A., et al. The timing of normal puberty and the age limits of sexual precocity: variations around the world, secular trends, and changes after migration. Endocr Rev 24 (2003) 668-693
8. Dattani M.T., and Hindmarsh P.C. Normal and abnormal puberty. In: Brook C., Clayton P., and Brown R. (Eds). Brook's clinical pediatric endocrinology. 5th edn. (2005), Blackwell, Oxford 183-210
9. Virdis R., Street M.E., Zampolli M., et al. Precocious puberty in girls adopted from developing countries. Arch Dis Child 78 (1998) 152-154
10. Herman-Giddens M., Slora E.J., Wasserman R.C., et al. Secondary sexual characteristics and menses in young girls seen in office practice: a study from the pediatric research in office settings network. Pediatrics 99 (1997) 505-512
11. Bridges N.A., Christopher J.A., Hindmarsh P.C., et al. Sexual precocity: sex incidence and aetiology. Arch Dis Child 70 (1994) 116-118
12. Teilmann G., Pedersen C.B., Jensen T.K., et al. Prevalence and incidence of precocious pubertal development in Denmark: an epidemiologic study based on national registries. Pediatrics 116 (2005) 1323-1328
13. Klein K.O. Precocious puberty: who has it? Who should be treated?. J Clin Endocrinol Metab 84 (1999) 411-414
14. Philip M., and Lazar L. Precocious puberty: growth and genetics. Horm Res 64 suppl 2 (2005) 56-61
15. Mahachoklertwattana P., Kaplan S.L., and Grumbach M.M. The leutinizing hormone-releasing hormone-secreting hypothalamic hamartoma is a congenital malformation: natural history. J Clin Endocrinol Metab 77 (1993) 118-124
16. Ahmed S.F., Marsh D.J., Weremowicz S., et al. Balanced translocation of 10q and 13q, including the PTEN gene, in a boy with a human chorionic gonadotropin-secreting tumor and the Bannayan-Riley-Ruvalcaba syndrome. J Clin Endocrinol Metab 84 (1999) 4665-4670
17. Fontoura M., Brauner R., Prevot C., et al. Precocious puberty in girls: early diagnosis of a slowly progressing variant. Arch Dis Child 64 (1989) 1170-1176
18. Stanhope R. Premature thelarche: clinical follow-up and indication for treatment. J Paed Endocrinol Metab 13 suppl 1 (2000) 827-830
19. Ibanez L., Potau N., Francois I., et al. Precocious pubarche, hyperinsulinism, and ovarian hyperandrogenism in girls: relation to reduced fetal growth. J Clin Endocrinol Metab 83 (1998) 3558-3562
20. Andrew M., Barr M., Davies E., et al. Congenital adrenal hyperplasia in a Nigerian child with a novel compound heterozygote mutation in CYP11B1. Clin Endocrinol (Oxford) 66 (2007) 602-603
21. Barnes N.D., Hayles A.B., and Ryan R.J. Sexual maturation in juvenile hypothyroidism. Mayo Clin Proc 48 (1973) 849-856
22. Kauli R., Galatzer A., Kornreich L., et al. Final height of girls with central precocious puberty, untreated versus treated with cyproterone acetate or GnRH analogue. A comparative study with re-evaluation of predictions by the Bayley-Pinneau method. Horm Res 47 (1997) 54-61
23. Johansson T., and Ritzen E.M. Very long-term follow-up of girls with early and late menarche. Endocr Dev 8 (2005) 126-136
24. Pinto S.M., and Garden A.S. Prepubertal menarche: a defined clinical entity. Am J Obstet Gynecol 195 (2006) 327-329
25. Aicardi G., Vignolo M., Milani S., et al. Assessment of skeletal maturity of the hand-wrist and knee: a comparison among methods. Am J Hum Biol 12 (2000) 610-615
26. Ng S.M., Kumar Y., Cody D., et al. Cranial MRI scans are indicated in all girls with central precocious puberty. Arch Dis Child 88 (2003) 414-418
27. Paris F., Servant N., Terouanne B., et al. A new recombinant cell bioassay for ultrasensitive determination of serum estrogenic bioactivity in children. J Clin Endocrinol Metab 87 (2002) 791-797
28. Merke D.P., and Cutler G.B. Evaluation and management of precocious puberty. Arch Dis Child 75 (1996) 269-271
29. Tuvemo T., Gustafsson J., Proos L.A., et al. Suppression of puberty in girls with short-acting intranasal versus subcutaneous depot GnRH agonist. Horm Res 57 (2002) 27-31
30. Roth C. Therapeutic potential of GnRH antagonists in the treatment of precocious puberty. Expert Opin Investig Drugs 11 9 (2002) 1253-1259
31. Bertelloni S., Baroncelli G.I., and Ferdeghini M. Final height, gonadal function and bone mineral density of adolescent males with central precocious puberty after therapy with gonadotrophin-releasing hormone analogues. Eur J Pediatr 159 (2000) 369-374
32. Mul D., Oostdijk W., Waelkens J.J., et al. Final height after treatment of early puberty in short adopted girls with gonadotrophin releasing hormone agonist with or without growth hormone. Clin Endocrinol (Oxford) 63 (2005) 185-190
33. Vottero A., Pedori S., Verna M., et al. Final height in girls with central idiopathic precocious puberty treated with gonadotropin-releasing hormone analog and oxandrolone. J Clin Endocrinol Metab 91 (2006) 1284-1287
34. Heger S., Partsch C.J., and Sippell W.G. Long-term outcome after depot gonadotropin-releasing hormone agonist treatment of central precocious puberty: final height, body proportions, body composition, bone mineral density, and reproductive function. J Clin Endocrinol Metab 84 (1999) 4583-4590
35. Heger S., Muller M., Ranke M., et al. Long-term GnRH agonist treatment for female central precocious puberty does not impair reproductive function. Mol Cell Endocrinol 255 (2006) 217-220
36. Antoniazzi F., and Zamboni G. Central precocious puberty: current treatment options. Pediatr Drugs 6 (2004) 211-231
37. Albers N., Jorgens S., Deiss D., et al. McCune-Albright syndrome-the German experience. J Pediatr Endocrinol Metab 15 suppl 3 (2002) 897-901
38. Feuillan P., Calis K., Hill S., et al. Letrozole treatment of precocious puberty in girls with the McCune-Albright syndrome; a pilot study. J Clin Endocrinol Metab (2007) [Epub ahead of print]